ArticleHistopathology2026

CDKN2A deletion in p16-negative/HPV-positive head and neck squamous cell carcinoma: Highlighting the molecular basis behind the limitation of relying on p16 immunohistochemistry as a surrogate marker for HPV involvement.

Trevor Teich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.